The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

September brings many asthma triggers that cause more asthma attacks, emergency room visits, and hospital stays than any other during the year. Asthma is a disease that narrows the airways and makes ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist (LAMA) or a Leukotriene Receptor Antagonist (LTRA) on top of a moderate-dose ...

The report estimates cleaner energy would also prevent 508 infant deaths. Nearly three million asthma attacks in children could be prevented by 2050 if the United States transitioned to electric ...

A major study of around 260,000 women shows that taking the progesterone-only contraceptive pill can increase asthma attacks in some women. The research, published in ERJ Open Research, shows an ...

FDA approves GSK's Exdensur for severe eosinophilic asthma, backed by Phase 3 data showing up to 58% fewer asthma attacks ...

Please provide your email address to receive an email when new articles are posted on . Combined oral contraceptive use was not linked to asthma attacks. The link between progestogen-only pill use and ...

Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It’s important to avoid triggers and monitor ...

The parents of a 13-year-old girl who died after an asthma attack led to a cardiac arrest have said they fear "other families will lose children because asthma is too easily dismissed". Emily Albino, ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

HENRY COUNTY, Ga. — A Metro Atlanta family is fighting for justice. Their son was having an asthma attack and they called for ...